These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8191267)

  • 21. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
    Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
    Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation.
    Hussain M; Soldevila-Pico C; Emre S; Luketic V; Lok AS;
    Liver Transpl; 2007 Aug; 13(8):1137-44. PubMed ID: 17663390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
    Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Viral hepatitis and liver transplantation].
    Samuel D; Féray C; Bismuth H
    Rev Prat; 1995 Jan; 45(2):197-201. PubMed ID: 7725022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
    Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation.
    Huang EJ; Wright TL; Lake JR; Combs C; Ferrell LD
    Hepatology; 1996 Mar; 23(3):396-404. PubMed ID: 8617417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
    Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
    Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.
    Angus PW; Locarnini SA; McCaughan GW; Jones RM; McMillan JS; Bowden DS
    Hepatology; 1995 Jan; 21(1):14-8. PubMed ID: 7806147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis.
    Naumann U; Protzer-Knolle U; Berg T; Leder K; Lobeck H; Bechstein WO; Gerken G; Hopf U; Neuhaus P
    Hepatology; 1997 Aug; 26(2):478-84. PubMed ID: 9252162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
    Takaki A; Yagi T; Yasunaka T; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Sato D; Nobuoka D; Utsumi M; Yasuda Y; Nakayama E; Miyake Y; Ikeda F; Shiraha H; Nouso K; Fujiwara T; Yamamoto K
    J Gastroenterol; 2013 Dec; 48(12):1373-83. PubMed ID: 23435670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B and C in the liver transplant recipient.
    Rosen HR; Martin P
    Semin Liver Dis; 2000; 20(4):465-80. PubMed ID: 11200416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma.
    Mazzaferro V; Brunetto MR; Pasquali M; Regalia E; Pulvirenti A; Baratti D; Makowka L; Van Thiel D; Bonino F
    J Viral Hepat; 1997 Jul; 4(4):235-42. PubMed ID: 9278221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
    Pei F; Zheng J; Du J; Zhong HH; Yang JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.